Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer)

ClinicalTrials.gov ID: NCT00095225

Public ClinicalTrials.gov record NCT00095225. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 1:35 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Multicenter, Randomized Clinical Trial to Evaluate the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy (Docetaxel or Pemetrexed) or Tarceva (Erlotinib) Compared With Chemotherapy (Docetaxel or Pemetrexed) Alone for Treatment of Recurrent or Refractory Non-Small Cell Lung Cancer

Study identification

NCT ID
NCT00095225
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Genentech, Inc.
Industry
Enrollment
122 participants

Conditions and interventions

Interventions

  • Avastin (bevacizumab) Drug
  • Tarceva (erlotinib HCl) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2004
Primary completion
Not listed
Completion
Oct 31, 2006
Last update posted
Jan 28, 2008

2004 – 2006

United States locations

U.S. sites
48
U.S. states
18
U.S. cities
43
Facility City State ZIP Site status
Comprehensive Blood and Cancer Center (TORI) Bakersfield California 93309
Bay Area Cancer Research Group Concord California 94520
Virginia K. Crosson Cancer Center (TORI) Fullerton California 92835
California Cancer Center, Inc Greenbrae California 94904
Wilshire Oncology Medical Group (TORI) Laverne California 91750
Pacific Shores Medical Group (TORI) Long Beach California 90813-3244
UCLA Medical Center PVUB 3360 Los Angeles California 90095
Central Hematology Oncology Medical Group (TORI) Monterey Park California 91754
North Valley Hematology/Oncology Medical Group (TORI) Northridge California 91328
Ventura County Hematology-Oncology Specialists (TORI) Oxnard California 93030
Cancer Care Associates Medical Group (TORI) Redondo Beach California 90277
UC Davis Cancer Center Sacramento California 95817
Kaiser Permanente/ San Diego San Diego California 92120
Sansum Santa Barbara Medical Foundation Clinic (TORI) Santa Barbara California 93105
Santa Barbara Hematology Oncology Medical Group, Inc (TORI) Santa Barbara California 93105
Kaiser Permanente Northern CA Vallejo California 94589
San Diego Cancer Center Medical Group (TORI) Vista California 92081
Comprehensive Cancer Care Specialist at Boca Raton Boca Raton Florida 33428
Florida Cancer Specialists Fort Myers Florida 33901
The Florida Cancer Institute(TORI) Orlando Florida 32804
MD Anderson Cancer Ctr- Orlando Orlando Florida 32806
Hematology and Oncology of Northeast Georgia, PC (TORI) Athens Georgia 30607
Medical Oncology Associates, PC (TORI) Augusta Georgia 30901
Suburban Hematology-Oncology Associates (TORI) Lawrenceville Georgia 30045
WellStar Cancer Research Office Marietta Georgia 30060
Atlanta Cancer Care (TORI) Roswell Georgia 30076
Rush-Presbyteriam Chicago Illinois 60612
University of Chicago Chicago Illinois 60637
Loyola Univ. Medical Center Maywood Illinois 60153
Hematology Oncology Consultants Naperville Illinois 60540
Oncoloy Hematology Associates of Central Illinois, PC (TORI) Peoria Illinois 61615
Norton Healthcare Louisville Oncology Louisville Kentucky 40202
Ochsner Cancer Inst. New Orleans Louisiana 70121
Maine Center for Cancer Medicine and Blood Disorders Scarborough Maine 04074
Methodist Cancer Center-Oncology Research Omaha Nebraska 68114
Comprehensive Cancer Centers of Nevada (TORI) Las Vegas Nevada 89109
Summit Medical Group Overlook Oncology Center Summit New Jersey 07901
Cancer Research of Long Island Great Neck New York 11023
Northwestern Carolina Oncology and Hematology Hickory North Carolina 28603
Mid Dakota Clinic Bismarck North Dakota 58501
Earle A. Chiles Research Institute Portland Oregon 97213
Kaiser Permanente Northwest Region Portland Oregon 97227
Univ. of Pittsburgh Cancer Center Inst. Pittsburgh Pennsylvania 15232
University of Tenn. Cancer Ins Memphis Tennessee 38104
The West Cancer Clinic Memphis Tennessee 38120
M.D. Anderson Houston Texas 77030
Virginia Mason Medical Center Seattle Washington 98101
Internal Medicine Associates of Yakima Yakima Washington 98902

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00095225, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 28, 2008 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00095225 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →